2'‑Hydroxyflavanone inhibits epithelial‑mesenchymal transition, and cell migration and invasion via suppression of the Wnt/β‑catenin signaling pathway in prostate cancer.

Despite the availability of a number of treatment options, certain cases of primary prostate cancer (PCa) will develop into metastatic PCa, in which epithelial‑mesenchymal transition (EMT) serves an important role. Recently, a natural flavonoid known as 2'‑hydroxyflavanone (2HF) exerts remarkable anticancer activity on various types of cancer. Our previous study demonstrated that 2HF could promote apoptosis and inhibit the proliferation of PCa cells, but whether 2HF is involved in the regulation of EMT, and cell migration and invasion in metastatic PCa remains unknown. The present study used two different metastatic PCa cell lines (PC‑3 and DU145) to investigate the effects of 2HF on EMT, and cell migration and invasion. The results demonstrated that 2HF could inhibit EMT, and cell migration and invasion through the Wnt/β‑catenin signaling pathway by suppressing GSK‑3β phosphorylation, β‑catenin expression and transactivation. In conclusion, the present study revealed a novel function of 2HF, which may be used to prevent or treat PCa metastasis.

• Publication year

  2018

• Venue

  Oncology Report

• Publication date

  2018-08-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3892/or.2018.6678PMID 30226607
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gold-quercetin nanoparticles prevent metabolic endotoxemia-induced kidney injury by regulating TLR4/NF-κB signaling and Nrf2 pathway in high fat diet fed mice

  2017cited by this paper
• 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer

  2017cited by this paper
• Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks

  2016cited by this paper
• Nanodiamonds coupled with 5,7-dimethoxycoumarin, a plant bioactive metabolite, interfere with the mitotic process in B16F10 cells altering the actin organization

  2016cited by this paper
• Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues

  2016cited by this paper
• Interaction between Wnt/β-catenin pathway and microRNAs regulates epithelial-mesenchymal transition in gastric cancer (Review).

  2016cited by this paper
• Global Cancer Incidence and Mortality Rates and Trends—An Update

  2015influential reference
• 2'-Hydroxyflavanone: A promising molecule for kidney cancer prevention.

  2015cited by this paper
• Metabolic and biological profile of autochthonous Vitis vinifera L. ecotypes.

  2015cited by this paper
• 2’-Hydroxyflavanone Induces Apoptosis of Human Osteosarcoma 143 B Cells by Activating the Extrinsic TRAIL- and Intrinsic Mitochondria-Mediated Pathways

  2014cited by this paper
• 2'-hydroxyflavanone inhibits prostate tumor growth through inactivation of AKT/STAT3 signaling and induction of cell apoptosis.

  2014cited by this paper
• AKR1C3 as a target in castrate resistant prostate cancer.

  2013cited by this paper
• Enhancing Effect of a Cysteinyl Thiol on the Antioxidant Activity of Flavonoids and Identification of the Antioxidative Thiol Adducts of Myricetin

  2013cited by this paper
• Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanone.

  2013cited by this paper
• TGF-&bgr; signaling and epithelial–mesenchymal transition in cancer progression

  2013cited by this paper
• Wnt/β-catenin signaling and disease.

  2012cited by this paper
• 2'-Hydroxyflavanone induces apoptosis through Egr-1 involving expression of Bax, p21, and NAG-1 in colon cancer cells.

  2012cited by this paper
• Independent Interactions of Phosphorylated β-Catenin with E-Cadherin at Cell-Cell Contacts and APC at Cell Protrusions

  2010cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Wnt/beta-catenin signaling: components, mechanisms, and diseases.

  2009cited by this paper
• Biomarkers for epithelial-mesenchymal transitions.

  2009cited by this paper
• Emerging therapies in castrate-resistant prostate cancer

  2009cited by this paper
• Proximal events in Wnt signal transduction

  2009cited by this paper
• Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

  2009cited by this paper
• Flavanone and 2'-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway.

  2007cited by this paper
• Quercetin-induced induction of the NO/cGMP pathway depends on Ca2+-activated K+ channel-induced hyperpolarization-mediated Ca2+-entry into cultured human endothelial cells.

  2005cited by this paper
• Natural Inhibitors of Carcinogenesis

  2004cited by this paper
• Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation.

  2004cited by this paper
• Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

  2004cited by this paper
• Potential therapeutic applications of some antinutritional plant secondary metabolites.

  2003cited by this paper
• Anti‐inflammatory and analgesic effects of paeonol in carrageenan‐evoked thermal hyperalgesia

  2003cited by this paper
• CoCl2, a Chemical Inducer of Hypoxia‐Inducible Factor‐1, and Hypoxia Reduce Apoptotic Cell Death in Hepatoma Cell Line HepG2

  2002cited by this paper
• Soy isoflavones increase latency of spontaneous mammary tumors in mice.

  2002cited by this paper

• 2'-Hydroxyflavanone inhibits bladder cancer cell proliferation and angiogenesis via regulating miR-99a-5p/mTOR signaling.

  2025cites this paper
• Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies

  2024cites this paper
• Wnt/β-catenin-driven EMT regulation in human cancers

  2024cites this paper
• New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials.

  2023cites this paper
• Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review

  2023cites this paper
• Flavonoids on the Frontline against Cancer Metastasis

  2023cites this paper
• Flavonoids as regulators of TIMPs expression in cancer: Consequences, opportunities, and challenges.

  2022cites this paper
• 2′-Hydroxyflavanone: A Bioactive Compound That Protects against Cancers

  2022cites this paper
• β-ionone Inhibits Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Cells by Negatively Regulating the Wnt/β-Catenin Pathway.

  2022cites this paper
• The subgroup of 2'-hydroxy-flavonoids: Molecular diversity, mechanism of action, and anticancer properties.

  2021cites this paper
• Phenotypic plasticity and lineage switching in prostate cancer

  2020cites this paper
• 2'-Hydroxyflavanone prevents LPS-induced inflammatory response and cytotoxicity in murine macrophages.

  2020cites this paper
• Flavonoids in Cancer Metastasis

  2020influential citation
• MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma

  2020cites this paper
• Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway.

  2020cites this paper
• 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling.

  2019cites this paper
• Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer

  2019cites this paper